SYMBRAHALE Trademark

Trademark Overview

On Thursday, May 12, 2022, a trademark application was filed for SYMBRAHALE with the United States Patent and Trademark Office. The USPTO has given the SYMBRAHALE trademark a serial number of 97408274. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, April 23, 2024. This trademark is owned by AstraZeneca AB. The SYMBRAHALE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of diseases and disorders of the respiratory systems
symbrahale

General Information

Serial Number97408274
Word MarkSYMBRAHALE
Filing DateThursday, May 12, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, April 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of diseases and disorders of the respiratory systems

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Wednesday, December 14, 2022NON-FINAL ACTION E-MAILED
Monday, May 16, 2022NEW APPLICATION ENTERED
Tuesday, May 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 12, 2022ASSIGNED TO EXAMINER
Wednesday, December 14, 2022NON-FINAL ACTION WRITTEN
Wednesday, December 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 3, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, March 3, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, June 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 7, 2023ASSIGNED TO LIE
Tuesday, November 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, February 5, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, March 5, 2024ASSIGNED TO PETITION STAFF
Thursday, March 7, 2024CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, March 13, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, March 14, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, April 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 8, 2024TEAS DELETE 1(B) BASIS RECEIVED

Related Keywords

symbrahale disorders respiratory systems diseases treatment preparations substances pharmaceutical